Goodwin represented Myrobalan Therapeutics on the matter. Myrobalan Therapeutics announced its $24 million Series A financing. The round was led by Co-win Ventures, with participation from...
Myrobalan Therapeutics’ $24 Million Series A Funding Round
TPI Composites, Inc.’s Refinancing Transaction with Oaktree
Lazard acted as TPI’s financial advisor. Goodwin Procter LLP acted as TPI’s legal advisor and Sullivan & Cromwell LLP acted as Oaktree’s legal advisor. TPI Composites,...
Miro’s Acquisition of Freehand
Goodwin advised Miro in its acquisition of Freehand. Miro has acquired the visual collaboration platform, Freehand, from InVision. The deal includes the technology and brand assets, customer...
LENZ Therapeutics’ Merger with Graphite Bio
Wilson Sonsini Goodrich & Rosati is representing LENZ Therapeutics in the transaction, Goodwin Procter is representing Graphite Bio and Latham & Watkins is representing the placements...
Acino’s Acquisition of M8 Pharmaceuticals
Banco J.P. Morgan S.A. is acting as exclusive financial advisor, Goodwin LLP as exclusive legal advisor, and PWC as exclusive accounting and tax advisor to Acino....
Korro Bio and Frequency Therapeutics’ Merger Agreement
Goodwin Procter is serving as legal counsel to Korro Bio, Latham & Watkins is serving as Frequency Therapeutics’ legal counsel, and Davis Polk is serving as...
OncoC4’s Strategic Collaboration with BioNTech
Goodwin advised OncoC4 on the deal. OncoC4 announced its agreement with BioNTech SE pursuant to which BioNTech receives an exclusive worldwide license to co-develop and commercialize OncoC4’s...
Bicara Therapeutics’ $108 Million Series B Financing
Goodwin Procter advised Bicara Therapeutics on the deal. Bicara Therapeutics announced the completion of its oversubscribed $108 million Series B financing to advance the company’s lead program...
Citrix Systems’ $16.5 Billion Acquisition of Vista Equity Partners and Evergreen Coast Capital’s Affiliates
Goodwin Procter advised Citrix Systems on the deal. Citrix Systems announced its acquisition by affiliates of Vista Equity Partners and Evergreen Coast Capital Corporation, an affiliate of...
Vista and Evergreen’s $16.5 Billion Acquisition of Citrix
Kirkland & Ellis and Kinstellar advised Vista, and Gibson, Dunn & Crutcher and Debevoise & Plimpton advised Evergreen. Goodwin Procter represented Citrix in the transaction. Wilson...
Toast’s $1.0 Billion IPO
Goodwin Procter advised Toast, Inc. on the deal while Sullivan & Cromwell represented the underwriters. Toast, Inc. (NYSE: TOST) announced its initial public offering of 25,000,000 shares...
AbCellera’s Acquisition of TetraGenetics
Goodwin Procter advised AbCellera on the deal. AbCellera (Nasdaq: ABCL) announced its acquisition of TetraGenetics. AbCellera is a technology company with a centralized operating system for next-generation...